We recently demonstrated that patients with post-polycythemia vera/essential thrombocythemia MF are enriched in the polymorphic allele variant of the rs1024611 SNP of CCL2, and its presence correlates with adverse clinical features [25]. This evidence concerns the gene CCL2 and acquired polycythemia vera.